NCT06258109

Brief Summary

Primary objective: To determine whether pregnancy increases the risk of recurrent CeAD and delayed stroke in women with prior CeAD based on long-term data. Methods: Multicentric, observational case-control study based on pooled individual patient data from several stroke centers. Primary endpoint: Primary composite outcome measure includes the following outcomes: (i) occurrence of recurrent CeAD, (ii) occurrence of ischemic or hemorrhagic stroke, (iii) death.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
9 countries

12 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 11, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

December 13, 2024

Status Verified

December 1, 2024

Enrollment Period

1.9 years

First QC Date

January 11, 2024

Last Update Submit

December 12, 2024

Conditions

Keywords

Ischemic StrokeHemorrhagic Stroke

Outcome Measures

Primary Outcomes (1)

  • Number of participants with composite outcome measure - recurrent CeAD, ischemic stroke, hemorrhagic stroke and/or death

    The composite outcome measure includes the following outcome measures during the follow-up: (i) occurence of recurrent cervical artery dissection (CeAD), (ii) occurrence of any ischemic stroke, (iii) occurrence of any hemorrhagic stroke, (iv) death.

    From date of first CeAD until date of latest follow-up assessed up to 35 years

Secondary Outcomes (5)

  • Number of participants with recurrent cervical artery dissection

    From date of first CeAD until date of latest follow-up assessed up to 35 years

  • Number of participants with new ischemic stroke

    From date of first CeAD until date of latest follow-up assessed up to 35 years

  • Number of participants with new hemorrhagic stroke

    From date of first CeAD until date of latest follow-up assessed up to 35 years

  • Number of participants with death

    From date of first CeAD until date of latest follow-up assessed up to 35 years

  • Functional outcome as assessed by modified Rankin Scale (mRS)

    At date of latest, individual follow-up assessed up to 35 years after first CeAD

Study Arms (2)

Women with pregnancy after index CeAD

Women who became pregnant at least once after first index CeAD

Women without pregnancy after index CeAD

Women who did not became pregnant after first index CeAD

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Female patients aged ≥18 years with prior CeAD.

You may qualify if:

  • female
  • prior symptomatic cervical artery dissection (= index CeAD)
  • at least one long-term follow-up visit (at least 6 months after the initial event)
  • with information available on outcome events:
  • recurrent dissection
  • ischemic stroke
  • hemorrhagic stroke
  • functional outcome assessed by mRS score
  • with data on pregnancy after the initial event
  • at least 18 years old at the initial event

You may not qualify if:

  • Male patients
  • Age \<18 years
  • No long-term follow-up available or long-term follow-up \< 6 months after initial event
  • No data on pregnancy after initial event available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

University of Utah

Salt Lake City, Utah, 84112, United States

RECRUITING

University of Virginia

Charlottesville, Virginia, 22908, United States

RECRUITING

Stroke Unit Sanatorio Allende

Córdoba, X5000BFB, Argentina

RECRUITING

Department of Neurology, Medical University of Innsbruck

Innsbruck, Tyrol, 6020, Austria

RECRUITING

Helsinki University Central Hospital

Helsinki, Finland

RECRUITING

Charité Universitätsmedizin, Centrum für Schlaganfallforschung

Berlin, 10117, Germany

RECRUITING

Neurologische Klinik und Poliklinik, LMU Klinikum Campus Großhadern

Munich, 81377, Germany

RECRUITING

Hadassah-Hebrew University Medical Center

Jerusalem, 91120, Israel

RECRUITING

Neurology Clinic, University of Brescia

Brescia, Italy

RECRUITING

Stroke Clinic, National Institute of Neurology and Neurosurgery Manuel Velasco Suárez

Mexico City, 14269, Mexico

RECRUITING

University Hospital Basel, Stroke Center

Basel, 4031, Switzerland

RECRUITING

University Hospital Zurich, Stroke Center

Zurich, Switzerland

RECRUITING

MeSH Terms

Conditions

Pregnancy ComplicationsIschemic StrokeHemorrhagic Stroke

Condition Hierarchy (Ancestors)

Female Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesStrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Stefan T Engelter, MD

    University Hospital, Basel, Switzerland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2024

First Posted

February 14, 2024

Study Start

January 1, 2023

Primary Completion

December 1, 2024

Study Completion

July 1, 2025

Last Updated

December 13, 2024

Record last verified: 2024-12

Locations